Home » Medical Devices » Japan HC Cold Chain Market

Japan HC Cold Chain Market By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, Others); By Services (Transportation, Storage, Packaging, Labeling, Others); By End User (Hospitals & Clinics, Pharmaceutical Companies, Biopharmaceutical and Biotechnology Companies, Others); By Mode of Delivery (Last-Mile Delivery, Hubs-to-Distributor); By Temperature Range (Ambient, Refrigerated, Frozen, Cryogenic); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Japan HC Cold Chain Market Size 2023	USD 4,183.27 million
Japan HC Cold Chain Market, CAGR	3.65%
Japan HC Cold Chain Market Size 2032	USD 5,776.17 million

Market Overview

The Japan HC Cold Chain market is projected to grow from USD 4,183.27 million in 2023 to an estimated USD 5,776.17 million by 2032, with a compound annual growth rate (CAGR) of 3.65% from 2024 to 2032. This growth is driven by the increasing demand for temperature-sensitive healthcare products, such as vaccines, biologics, and other pharmaceutical products, which require stringent cold storage and transportation conditions.

Key market drivers include the rising prevalence of chronic diseases, which has led to an increased demand for temperature-sensitive biologics and pharmaceuticals, as well as the government’s focus on strengthening the healthcare infrastructure. Additionally, advancements in cold chain logistics technology, including better temperature monitoring and control systems, are expected to further boost market growth. The trend toward outsourcing cold chain logistics services to specialized providers is also gaining traction, providing opportunities for market expansion.

Geographically, the market is concentrated in urban regions such as Tokyo, Osaka, and Nagoya, where the majority of healthcare facilities and pharmaceutical companies are located. Key players in the Japan HC Cold Chain market include Nippon Express Co., Ltd., Yamato Holdings Co., Ltd., Nichirei Corporation, and Konoike Transport Co., Ltd., which are all investing heavily in expanding their cold chain logistics capabilities to cater to the growing demand in the healthcare sector.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Demand for Temperature-Sensitive Healthcare Products

The increasing demand for temperature-sensitive healthcare products is a key driver of Japan’s healthcare cold chain market. As the population ages and chronic diseases become more prevalent, there is growing need for biologics, vaccines, and other pharmaceuticals requiring precise temperature control. Government data shows Japan’s elderly population continues to expand rapidly, driving higher healthcare utilization. Industry surveys indicate pharmaceutical companies are developing more temperature-sensitive therapies to address age-related conditions. The COVID-19 pandemic highlighted the critical importance of cold chain infrastructure for vaccine distribution. Healthcare providers report rising use of biologics and other products needing refrigeration or freezing. Cold chain logistics companies note increased volumes of temperature-controlled shipments for the healthcare sector. Hospitals and clinics are expanding on-site cold storage capacity to handle more temperature-sensitive medications and vaccines. Pharmaceutical manufacturers are investing in specialized packaging and monitoring systems to maintain product integrity during transport and storage. Overall, stakeholders across Japan’s healthcare system emphasize cold chain capabilities as essential for delivering innovative therapies to patients. As more temperature-sensitive products enter the market, reliable end-to-end cold chain solutions are becoming a necessity rather than a luxury.

Technological Advancements in Cold Chain Logistics

Technological innovations are significantly enhancing cold chain capabilities in Japan’s healthcare sector. Industry reports highlight widespread adoption of IoT-enabled temperature monitoring systems that provide real-time tracking and alerts. Leading logistics providers have deployed AI-powered predictive analytics to optimize routes and prevent temperature excursions. Surveys of pharmaceutical companies show increased use of phase change materials and vacuum insulated packaging to maintain ultra-low temperatures for sensitive biologics. Transportation firms are expanding fleets of advanced refrigerated vehicles with multi-temperature zones and telematics. Warehousing operators report investments in automated storage and retrieval systems for temperature-controlled environments. Blockchain solutions are being piloted to enhance traceability and security throughout the cold chain. Government agencies have funded R&D into novel refrigeration technologies like magneto-caloric cooling. Healthcare facilities are upgrading to smart freezers and refrigerators with continuous monitoring capabilities. Packaging suppliers are developing sustainable insulation materials to reduce environmental impact. Overall, cold chain stakeholders emphasize how technological advancements are improving reliability, efficiency and visibility across temperature-controlled logistics networks. As innovations continue, industry experts anticipate further enhancements in maintaining product integrity from manufacturer to patient.

Government Initiatives and Regulatory Support

Government policies and regulations are playing a crucial role in advancing Japan’s healthcare cold chain capabilities. The Ministry of Health, Labour and Welfare has implemented stringent Good Distribution Practice guidelines for handling temperature-sensitive pharmaceuticals. Industry surveys show widespread efforts by companies to achieve GDP certification and compliance. Government agencies have funded upgrades to vaccine storage and distribution infrastructure at hospitals and clinics nationwide. The Ministry of Economy, Trade and Industry has provided grants and tax incentives for cold chain technology development and adoption. Regulatory bodies have established standards for temperature-controlled packaging, transportation, and storage of various healthcare products. Local governments have supported expansion of refrigerated warehousing capacity in key logistics hubs. Public-private partnerships have been formed to enhance cold chain preparedness for future pandemics and health emergencies. Healthcare regulators have increased inspection and auditing of cold chain operations to ensure product safety and quality. Overall, government initiatives are creating a supportive environment for cold chain investment and innovation. Industry stakeholders report that clear regulatory frameworks and financial support are accelerating improvements in Japan’s healthcare cold chain infrastructure and capabilities.

Growing Trend of Outsourcing Cold Chain Services

The growing trend of outsourcing cold chain services to specialized third-party logistics (3PL) providers is another significant driver of the Japan HC Cold Chain market. As the complexity of cold chain logistics increases, many pharmaceutical and biotechnology companies are opting to outsource these services to 3PL providers with expertise in managing temperature-sensitive supply chains. This allows companies to focus on their core competencies, such as drug development and manufacturing, while leveraging the specialized knowledge and infrastructure of 3PL providers to ensure the safe and efficient distribution of their products. Outsourcing also offers cost advantages, as it reduces the need for companies to invest in their own cold chain infrastructure and technology. In Japan, the demand for outsourced cold chain services has been growing steadily, driven by the increasing volume of temperature-sensitive products and the need for more sophisticated logistics solutions. 3PL providers in the country are expanding their service offerings to include end-to-end cold chain management, from warehousing and transportation to temperature monitoring and regulatory compliance. This trend is expected to continue as the HC Cold Chain market in Japan grows, with more companies recognizing the benefits of outsourcing their cold chain logistics to specialized providers.

Market Trends

Integration of Advanced Technology in Cold Chain Logistics

The Japan HC Cold Chain market is experiencing a significant shift towards advanced technology integration to enhance efficiency and reliability. Companies are increasingly adopting Internet of Things (IoT) devices for real-time temperature and humidity monitoring throughout the supply chain. For instance, a leading Japanese pharmaceutical distributor has implemented IoT sensors in their refrigerated trucks, allowing them to track temperature fluctuations and respond promptly to any deviations. Blockchain technology is gaining traction for ensuring traceability and transparency. A major healthcare logistics provider in Japan has partnered with a blockchain startup to create an immutable record of cold chain processes, enhancing trust and regulatory compliance. Artificial intelligence and machine learning are being utilized to optimize route planning and inventory management. A prominent cold chain solutions company in Tokyo has reported significant improvements in delivery times and reduction in temperature excursions after implementing AI-driven route optimization. These technological advancements are not only improving operational efficiency but also helping to reduce costs and minimize product loss, making them a key focus for companies in the market.

Growing Focus on Sustainability and Environmental Impact

Sustainability has become a central focus in the Japan HC Cold Chain market, with companies actively seeking ways to reduce their environmental footprint. The adoption of energy-efficient refrigeration systems is on the rise. For example, a major cold storage facility in Osaka has recently upgraded to a state-of-the-art cooling system that uses natural refrigerants, significantly reducing its energy consumption and greenhouse gas emissions. The use of eco-friendly packaging materials is also gaining momentum. A leading pharmaceutical manufacturer has switched to biodegradable insulation materials for its temperature-controlled shipments, reporting positive feedback from environmentally conscious customers. In transportation, there’s a growing interest in electric and hybrid refrigerated vehicles. A national logistics company has announced plans to convert 30% of its cold chain fleet to electric vehicles over the next five years. Additionally, renewable energy adoption is increasing, with several cold storage facilities installing solar panels to power their operations. This shift towards sustainability is partly driven by government initiatives aligning with Japan’s commitment to reducing carbon emissions. As a result, companies are increasingly viewing sustainable practices as a competitive advantage in the HC Cold Chain market.

Market Restraints and Challenges

High Operational Costs and Infrastructure Investment

The Japan HC Cold Chain market faces significant challenges due to high operational costs and substantial infrastructure investments. Establishing and maintaining cold chain facilities requires considerable capital, including specialized storage units, refrigerated vehicles, and advanced monitoring systems. Energy expenses for refrigeration are a major concern, with costs fluctuating based on market conditions. For instance, a survey by the Japan Cold Chain Association revealed that energy costs account for a substantial portion of operational expenses for cold chain companies. Additionally, the need for regular maintenance and upgrades to meet stringent regulatory standards further increases financial burdens. The Japanese Ministry of Economy, Trade and Industry has reported that small and medium-sized enterprises often struggle to enter or expand in the market due to these high costs. Labor expenses also contribute significantly, as skilled workers are essential for managing complex cold chain operations. A recent industry report highlighted that many companies in Japan are investing in automation and IoT technologies to offset rising labor costs, but this requires substantial upfront investment.

Regulatory Compliance and Complex Supply Chain Management

Navigating regulatory compliance and managing complex supply chains pose significant challenges in the Japan HC Cold Chain market. The healthcare cold chain is subject to strict regulations, including Good Distribution Practice (GDP) guidelines, which demand meticulous documentation and temperature control throughout the supply chain. A survey conducted by a leading pharmaceutical logistics provider in Japan found that many companies struggle to keep up with evolving regulatory requirements, particularly when operating across multiple regions. The Japan Pharmaceutical Manufacturers Association has reported an increase in compliance-related issues in recent years, highlighting the complexity of the regulatory landscape. Managing a multi-stakeholder supply chain adds another layer of complexity, requiring seamless coordination between manufacturers, logistics providers, and healthcare facilities. Japan’s unique geographic features, including its mountainous terrain and numerous islands, further complicate logistics. A government study on pharmaceutical distribution revealed that maintaining temperature control during transportation across these diverse landscapes is a significant challenge. Additionally, the densely populated urban areas in Japan present their own set of logistical hurdles, as reported by several major cold chain logistics companies operating in the country.

Market Segmentation Analysis

By product

The Japan HC Cold Chain market is driven by the critical need for temperature control across various product segments. Vaccines play a vital role, especially with ongoing immunization efforts. For instance, a survey by the Japan Vaccine Industry Association found that over 90% of healthcare facilities reported increased cold chain demands for vaccine storage and distribution in recent years. Biopharmaceuticals, particularly biologics, are also key contributors due to their temperature sensitivity. Government data indicates a steady rise in biologic drug approvals, necessitating more sophisticated cold chain solutions. Clinical trial materials require precise temperature management, with a major pharmaceutical company reporting that temperature excursions decreased by 40% after implementing advanced cold chain monitoring. Other temperature-sensitive products like blood components and diagnostic reagents further drive market growth. A leading medical device manufacturer noted that cold chain breaches for sensitive reagents dropped significantly after partnering with specialized logistics providers. This diverse product landscape has spurred innovation in customized cold chain technologies tailored for healthcare applications.

By services

In the Japan HC Cold Chain market, transportation services form the core infrastructure. A survey of healthcare logistics providers revealed that over 75% have invested in expanding their fleet of temperature-controlled vehicles in the past 3 years. Cold storage facilities are equally crucial, with government data showing a 30% increase in pharmaceutical-grade refrigerated warehousing capacity since 2018. Packaging innovations have also accelerated, as evidenced by a major packaging supplier reporting double-digit growth in sales of insulated containers designed for biologics. Labeling and monitoring services have seen increased adoption, with a leading cold chain technology company noting that demand for their real-time temperature tracking solutions has grown exponentially. Supporting services like inventory management and regulatory consulting are increasingly valued, as reflected in a pharmaceutical industry association report highlighting that over 60% of member companies now outsource some aspect of their cold chain management to specialized service providers. This comprehensive service ecosystem enables end-to-end temperature control and enhances the reliability of healthcare product distribution across Japan.

Segments

Based on Product

Vaccines
Biopharmaceuticals
Clinical Trial Materials
Others

Based on Services

Transportation
Storage
Packaging
Labeling
Others

Based on End User

Hospitals & Clinics
Pharmaceutical Companies
Biopharmaceutical and Biotechnology Companies
Others

Based on Mode of Delivery

Last-Mile Delivery
Hubs-to-Distributor

Based on Temperature Range

Ambient
Refrigerated
Frozen
Cryogenic

Based on Region

Urban
Rural

Regional Analysis

Tokyo Region (35%):

Tokyo, the capital city, holds the largest market share in the Japan HC Cold Chain market, accounting for approximately 35% of the overall market. For instance, a government survey found that Tokyo hosts the highest concentration of pharmaceutical companies and research institutions in Japan. The region’s advanced logistics infrastructure, including major international airports and ports, facilitates efficient import and export of temperature-sensitive healthcare products. A industry report highlighted that Tokyo’s large and aging population drives substantial demand for healthcare services and cold chain logistics. The survey also noted that many global biopharmaceutical firms have established regional headquarters or R&D centers in Tokyo, further boosting the need for specialized cold chain solutions in the area.

Osaka Region (25%):

Osaka is another key region in the Japan HC Cold Chain market, contributing around 25% to the overall market share. For example, an industry association report identified Osaka as home to several leading domestic pharmaceutical and biotechnology companies. Government data showed that Osaka’s ports handle a significant volume of healthcare-related imports and exports requiring cold chain logistics. A logistics industry survey found that Osaka has invested heavily in developing state-of-the-art cold storage facilities and specialized transportation services to meet growing demand. The report also noted Osaka’s high concentration of healthcare providers and research institutions as a major driver for cold chain solutions in the region. Additionally, government initiatives to promote Osaka as a biomedical innovation hub have further stimulated growth in the local cold chain market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Cardinal Health
AmerisourceBergen
Envirotainer
Thermo King
FedEx
Sonoco ThermoSafe
Phoenix Group
B Medical System
Agility
DoKaSch

Competitive Analysis

The Japan HC Cold Chain market is characterized by the presence of both global and regional players, each bringing unique strengths to the market. Cardinal Health and AmerisourceBergen are dominant in pharmaceutical distribution, leveraging their extensive networks and advanced cold chain solutions to maintain market leadership. Envirotainer and DoKaSch specialize in providing temperature-controlled air cargo containers, essential for the global transportation of sensitive healthcare products. Thermo King and Sonoco ThermoSafe are key players in cold chain logistics technology, offering innovative refrigeration systems and packaging solutions. FedEx, with its expansive global logistics network, plays a critical role in the last-mile delivery of temperature-sensitive products. Phoenix Group and Agility bring strong regional expertise, particularly in the efficient distribution and handling of healthcare products. B Medical System is known for its specialized cold storage solutions, catering to healthcare facilities and laboratories. Together, these companies drive competition and innovation within the market.

Recent Developments

In September 2024, Thermo King announced it would unveil its latest electric innovations for cold chain transport at the IAA Transportation show in Germany. While not specific to Japan, these innovations are likely to impact the Japanese market as well.

In 2021, DoKaSch strengthened its presence in Japan by establishing a dedicated subsidiary, DoKaSch Temperature Solutions K.K., in Tokyo and opening a new service station at Narita International Airport. This expansion aimed to provide better access to their “Opticooler” temperature-controlled packaging solution for Japanese customers.

Market Concentration and Characteristics

The Japan HC Cold Chain market is moderately concentrated, with a mix of global and regional players dominating the landscape. Major international companies like Cardinal Health, AmerisourceBergen, and FedEx bring extensive experience and advanced logistics capabilities, contributing to the high level of service quality and reliability in the market. However, regional firms such as Phoenix Group and Agility play a significant role in providing localized expertise and tailored solutions to meet specific market needs. The market is characterized by a strong focus on technological innovation, stringent regulatory compliance, and the growing importance of sustainability in cold chain operations. Despite the presence of a few dominant players, the market remains competitive, with ongoing investments in infrastructure, technology, and service diversification driving growth and differentiation among key participants.

Report Coverage

The research report offers an in-depth analysis based on Product, Services, End User, Mode of Delivery, Temperature Range and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Japan HC Cold Chain market is expected to see significant investments in expanding cold storage facilities and advanced transportation networks, driven by the rising demand for temperature-sensitive healthcare products.

The integration of IoT, AI, and blockchain in cold chain logistics will enhance real-time monitoring, improve efficiency, and ensure greater transparency across the supply chain.

Companies will increasingly adopt sustainable practices, such as energy-efficient refrigeration systems and eco-friendly packaging, to reduce the environmental impact of cold chain operations.

The trend of outsourcing cold chain logistics to specialized third-party providers is likely to grow, as pharmaceutical and biotechnology companies focus on core competencies and cost efficiency.

Compliance with stringent regulations, including GDP standards, will continue to be a priority, driving investments in quality assurance and validation processes within the cold chain market.

The demand for efficient last-mile delivery solutions will increase, particularly in urban areas, to ensure the timely and safe delivery of temperature-sensitive healthcare products.

While Tokyo, Osaka, and Nagoya will remain dominant, other regions in Japan are expected to see increased investments in cold chain infrastructure, contributing to a more evenly distributed market growth.

As the biopharmaceutical sector continues to expand, the need for specialized cold chain solutions for biologics and advanced therapies will drive market growth.

Collaboration between pharmaceutical companies, logistics providers, and regulatory bodies will intensify, leading to more integrated and efficient cold chain networks.

The digitalization of cold chain processes, including the use of advanced data analytics and cloud-based platforms, will improve operational efficiency and decision-making across the industry.

CHAPTER NO. 1 : INTRODUCTION 14

1.1.1. Report Description 14

Purpose of the Report 14

USP & Key Offerings 14

1.1.2. Key Benefits for Stakeholders 14

1.1.3. Target Audience 15

1.1.4. Report Scope 15

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. Japan Healthcare Cold Chain Logistics Market Snapshot 16

2.1.1. Japan Healthcare Cold Chain Logistics Market, 2018 – 2032 (USD Million) 17

CHAPTER NO. 3 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – INDUSTRY ANALYSIS 18

3.1. Introduction 18

3.2. Market Drivers 19

3.2.1. Driving Factor 1 Analysis 19

3.2.2. Driving Factor 2 Analysis 20

3.3. Market Restraints 21

3.3.1. Restraining Factor Analysis 21

3.4. Market Opportunities 22

3.4.1. Market Opportunity Analysis 22

3.5. Porter’s Five Forces Analysis 23

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 24

4.1. Company Market Share Analysis – 2023 24

4.1.1. Japan Healthcare Cold Chain Logistics Market: Company Market Share, by Volume, 2023 24

4.1.2. Japan Healthcare Cold Chain Logistics Market: Company Market Share, by Revenue, 2023 25

4.1.3. Japan Healthcare Cold Chain Logistics Market: Top 6 Company Market Share, by Revenue, 2023 25

4.1.4. Japan Healthcare Cold Chain Logistics Market: Top 3 Company Market Share, by Revenue, 2023 26

4.2. Japan Healthcare Cold Chain Logistics Market Company Revenue Market Share, 2023 27

4.3. Company Assessment Metrics, 2023 28

4.3.1. Stars 28

4.3.2. Emerging Leaders 28

4.3.3. Pervasive Players 28

4.3.4. Participants 28

4.4. Start-ups /SMEs Assessment Metrics, 2023 28

4.4.1. Progressive Companies 28

4.4.2. Responsive Companies 28

4.4.3. Dynamic Companies 28

4.4.4. Starting Blocks 28

4.5. Strategic Developments 29

4.5.1. Acquisitions & Mergers 29

New Product Launch 29

Japan Expansion 29

4.6. Key Players Product Matrix 30

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 31

5.1. PESTEL 31

5.1.1. Political Factors 31

5.1.2. Economic Factors 31

5.1.3. Social Factors 31

5.1.4. Technological Factors 31

5.1.5. Environmental Factors 31

5.1.6. Legal Factors 31

5.2. Adjacent Market Analysis 31

CHAPTER NO. 6 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – BY PRODUCT SEGMENT ANALYSIS 32

6.1. Japan Healthcare Cold Chain Logistics Market Overview, by Product Segment 32

6.1.1. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Product, 2023 & 2032 33

6.1.2. Japan Healthcare Cold Chain Logistics Market Attractiveness Analysis, By Product 34

6.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 34

6.1.4. Japan Healthcare Cold Chain Logistics Market Revenue, By Product, 2018, 2023, 2027 & 2032 35

6.2. Vaccines 36

6.3. Biopharmaceuticals 37

6.4. Clinical Trial Materials 38

6.5. Others 39

CHAPTER NO. 7 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – BY SERVICES SEGMENT ANALYSIS 40

7.1. Japan Healthcare Cold Chain Logistics Market Overview, by Services Segment 40

7.1.1. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Services, 2023 & 2032 41

7.1.2. Japan Healthcare Cold Chain Logistics Market Attractiveness Analysis, By Services 42

7.1.3. Incremental Revenue Growth Opportunity, by Services, 2024 – 2032 42

7.1.4. Japan Healthcare Cold Chain Logistics Market Revenue, By Services, 2018, 2023, 2027 & 2032 43

7.2. Transportation 44

7.3. Storage 45

7.4. Packaging 46

7.5. Labeling 47

7.6. Others 48

CHAPTER NO. 8 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – BY END-USER SEGMENT ANALYSIS 49

8.1. Japan Healthcare Cold Chain Logistics Market Overview, by End-user Segment 49

8.1.1. Japan Healthcare Cold Chain Logistics Market Revenue Share, By End-user, 2023 & 2032 50

8.1.2. Japan Healthcare Cold Chain Logistics Market Attractiveness Analysis, By End-user 51

8.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 51

8.1.4. Japan Healthcare Cold Chain Logistics Market Revenue, By End-user, 2018, 2023, 2027 & 2032 52

8.2. Hospitals & Clinics 53

8.3. Pharmaceutical 54

8.4. Biopharmaceutical 55

8.5. Biotechnology Companies 56

8.6. Others 57

CHAPTER NO. 9 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – BY MODE OF DELIVERY SEGMENT ANALYSIS 58

9.1. Japan Healthcare Cold Chain Logistics Market Overview, by Mode of Delivery Segment 58

9.1.1. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Mode of Delivery, 2023 & 2032 59

9.1.2. Japan Healthcare Cold Chain Logistics Market Attractiveness Analysis, By Mode of Delivery 60

9.1.3. Incremental Revenue Growth Opportunity, by Mode of Delivery, 2024 – 2032 60

9.1.4. Japan Healthcare Cold Chain Logistics Market Revenue, By Mode of Delivery, 2018, 2023, 2027 & 2032 61

9.2. Last-Mile Delivery 62

9.3. Hubs-to-Distributor 63

CHAPTER NO. 10 : JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET – BY TEMPERATURE RANGE SEGMENT ANALYSIS 64

10.1. Japan Healthcare Cold Chain Logistics Market Overview, by Temperature Range Segment 64

10.1.1. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Temperature Range, 2023 & 2032 65

10.1.2. Japan Healthcare Cold Chain Logistics Market Attractiveness Analysis, By Temperature Range 66

10.1.3. Incremental Revenue Growth Opportunity, by Temperature Range, 2024 – 2032 66

10.1.4. Japan Healthcare Cold Chain Logistics Market Revenue, By Temperature Range, 2018, 2023, 2027 & 2032 67

10.2. Ambient 68

10.3. Refrigerated 69

10.4. Frozen 70

10.5. Cryogenic 71

CHAPTER NO. 11 : COMPANY PROFILES 72

11.1. Cardinal Health 72

11.1.1. Company Overview 72

11.1.2. Product Portfolio 72

11.1.3. Swot Analysis 72

11.1.4. Business Strategy 73

11.1.5. Financial Overview 73

11.2. Amerisource Bergen 74

11.3. Envirotainer 74

11.4. Thermoking 74

11.5. FedEx 74

11.6. Sonoco Thermosafe 74

11.7. Phoenix Group 74

11.8. B Medical Systems 74

11.9. Agility 74

11.10. Dokasch 74

CHAPTER NO. 12 : RESEARCH METHODOLOGY 75

12.1. Research Methodology 75

12.1.1. Phase I – Secondary Research 76

12.1.2. Phase II – Data Modeling 76

Company Share Analysis Model 77

Revenue Based Modeling 77

12.1.3. Phase III – Primary Research 78

12.1.4. Research Limitations 79

Assumptions 79

List of Figures

FIG NO. 1. Japan Healthcare Cold Chain Logistics Market Revenue, 2018 – 2032 (USD Million) 17

FIG NO. 2. Porter’s Five Forces Analysis for Japan Healthcare Cold Chain Logistics Market 23

FIG NO. 3. Company Share Analysis, 2023 24

FIG NO. 4. Company Share Analysis, 2023 25

FIG NO. 5. Company Share Analysis, 2023 25

FIG NO. 6. Company Share Analysis, 2023 26

FIG NO. 7. Japan Healthcare Cold Chain Logistics Market – Company Revenue Market Share, 2023 27

FIG NO. 8. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Product, 2023 & 2032 33

FIG NO. 9. Market Attractiveness Analysis, By Product 34

FIG NO. 10. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 34

FIG NO. 11. Japan Healthcare Cold Chain Logistics Market Revenue, By Product, 2018, 2023, 2027 & 2032 35

FIG NO. 12. Japan Healthcare Cold Chain Logistics Market for Vaccines, Revenue (USD Million) 2018 – 2032 36

FIG NO. 13. Japan Healthcare Cold Chain Logistics Market for Biopharmaceuticals, Revenue (USD Million) 2018 – 2032 37

FIG NO. 14. Japan Healthcare Cold Chain Logistics Market for Clinical Trial Materials, Revenue (USD Million) 2018 – 2032 38

FIG NO. 15. Japan Healthcare Cold Chain Logistics Market for Others, Revenue (USD Million) 2018 – 2032 39

FIG NO. 16. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Services, 2023 & 2032 41

FIG NO. 17. Market Attractiveness Analysis, By Services 42

FIG NO. 18. Incremental Revenue Growth Opportunity by Services, 2024 – 2032 42

FIG NO. 19. Japan Healthcare Cold Chain Logistics Market Revenue, By Services, 2018, 2023, 2027 & 2032 43

FIG NO. 20. Japan Healthcare Cold Chain Logistics Market for Transportation, Revenue (USD Million) 2018 – 2032 44

FIG NO. 21. Japan Healthcare Cold Chain Logistics Market for Storage, Revenue (USD Million) 2018 – 2032 45

FIG NO. 22. Japan Healthcare Cold Chain Logistics Market for Packaging, Revenue (USD Million) 2018 – 2032 46

FIG NO. 23. Japan Healthcare Cold Chain Logistics Market for Labeling, Revenue (USD Million) 2018 – 2032 47

FIG NO. 24. Japan Healthcare Cold Chain Logistics Market for Others, Revenue (USD Million) 2018 – 2032 48

FIG NO. 25. Japan Healthcare Cold Chain Logistics Market Revenue Share, By End-user, 2023 & 2032 50

FIG NO. 26. Market Attractiveness Analysis, By End-user 51

FIG NO. 27. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 51

FIG NO. 28. Japan Healthcare Cold Chain Logistics Market Revenue, By End-user, 2018, 2023, 2027 & 2032 52

FIG NO. 29. Japan Healthcare Cold Chain Logistics Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 53

FIG NO. 30. Japan Healthcare Cold Chain Logistics Market for Pharmaceutical, Revenue (USD Million) 2018 – 2032 54

FIG NO. 31. Japan Healthcare Cold Chain Logistics Market for Biopharmaceutical, Revenue (USD Million) 2018 – 2032 55

FIG NO. 32. Japan Healthcare Cold Chain Logistics Market for Biotechnology Companies, Revenue (USD Million) 2018 – 2032 56

FIG NO. 33. Japan Healthcare Cold Chain Logistics Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 34. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Mode of Delivery, 2023 & 2032 59

FIG NO. 35. Market Attractiveness Analysis, By Mode of Delivery 60

FIG NO. 36. Incremental Revenue Growth Opportunity by Mode of Delivery, 2024 – 2032 60

FIG NO. 37. Japan Healthcare Cold Chain Logistics Market Revenue, By Mode of Delivery, 2018, 2023, 2027 & 2032 61

FIG NO. 38. Japan Healthcare Cold Chain Logistics Market for Last-Mile Delivery, Revenue (USD Million) 2018 – 2032 62

FIG NO. 39. Japan Healthcare Cold Chain Logistics Market for Hubs-to-Distributor, Revenue (USD Million) 2018 – 2032 63

FIG NO. 40. Japan Healthcare Cold Chain Logistics Market Revenue Share, By Temperature Range, 2023 & 2032 65

FIG NO. 41. Market Attractiveness Analysis, By Temperature Range 66

FIG NO. 42. Incremental Revenue Growth Opportunity by Temperature Range, 2024 – 2032 66

FIG NO. 43. Japan Healthcare Cold Chain Logistics Market Revenue, By Temperature Range, 2018, 2023, 2027 & 2032 67

FIG NO. 44. Japan Healthcare Cold Chain Logistics Market for Ambient, Revenue (USD Million) 2018 – 2032 68

FIG NO. 45. Japan Healthcare Cold Chain Logistics Market for Refrigerated, Revenue (USD Million) 2018 – 2032 69

FIG NO. 46. Japan Healthcare Cold Chain Logistics Market for Frozen, Revenue (USD Million) 2018 – 2032 70

FIG NO. 47. Japan Healthcare Cold Chain Logistics Market for Cryogenic, Revenue (USD Million) 2018 – 2032 71

FIG NO. 48. Research Methodology – Detailed View 75

FIG NO. 49. Research Methodology 76

List of Tables

TABLE NO. 1. : Japan Healthcare Cold Chain Logistics Market: Snapshot 17

TABLE NO. 2. : Drivers for the Japan Healthcare Cold Chain Logistics Market: Impact Analysis 20

TABLE NO. 3. : Restraints for the Japan Healthcare Cold Chain Logistics Market: Impact Analysis 22

Frequently Asked Questions

What is the projected growth of the Japan HC Cold Chain market?

The Japan HC Cold Chain market is projected to grow from USD 4,183.27 million in 2023 to USD 5,776.17 million by 2032, with a CAGR of 3.65% from 2024 to 2032.

What factors are driving the growth of the Japan HC Cold Chain market?

The market growth is driven by the increasing demand for temperature-sensitive healthcare products, advancements in cold chain logistics technology, and a growing trend towards outsourcing logistics services.

Which regions in Japan dominate the HC Cold Chain market?

Tokyo, Osaka, and Nagoya are the key regions, with Tokyo holding the largest market share at 35%, followed by Osaka at 25%, and Nagoya at 20%.

Who are the major players in the Japan HC Cold Chain market?

Key players include Cardinal Health, AmerisourceBergen, Envirotainer, Thermo King, FedEx, Sonoco ThermoSafe, Phoenix Group, B Medical System, Agility, and DoKaSch.

Purchase Options

Single User

$1699

Multi User

$2699

Custom Report

$4699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –